October 21, 2019
MTI Secures $4.2M Financing Round
Formed in 2010 as a spin-off company from the University of Alberta in Canada, MTI specializes in innovative metabolomics-based diagnostics for the healthcare market. Our mission: saving lives through early detection.
read more...
METABOLOMICs the SCIENCE
There are more than 40,000 small molecule metabolites found in the human body. These metabolites can provide us with a snapshot of a patient's health, through the identification of distinct metabolomic fingerprints. Focused on driving novel research findings to commercial products, MTI is an innovative leader in bringing leading-edge metabolomics diagnostics to market.
read more...